Piety, Nathaniel Z.
Stutz, Julianne
Yilmaz, Nida
Xia, Hui
Yoshida, Tatsuro
Shevkoplyas, Sergey S.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HHSN268201300045C, R01HL117329)
Article History
Received: 22 September 2020
Accepted: 11 December 2020
First Online: 12 January 2021
Competing interests
: TY and SSS are inventors of the artificial microvascular network technology described in this article. NZP and SSS received compensation as consultants for Hemanext which is commercializing this technology. TY is a Director of Research & Development at Hemanext. SSS received research funding from Hemanext. All other authors declare no conflict of interest.